Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease

2012 ◽  
Vol 27 (4) ◽  
pp. 559-561 ◽  
Author(s):  
Raffaella Di Giacopo ◽  
Alfonso Fasano ◽  
Davide Quaranta ◽  
Giacomo Della Marca ◽  
Francesco Bove ◽  
...  
2013 ◽  
Vol 14 ◽  
pp. e34-e35
Author(s):  
P. Ratti ◽  
M. Sierra-Peña ◽  
J. Bastin ◽  
R. Manni ◽  
M. Simonetta-Moreau ◽  
...  

2008 ◽  
Vol 23 (10) ◽  
pp. 1441-1445 ◽  
Author(s):  
Elena Sinforiani ◽  
Claudio Pacchetti ◽  
Roberta Zangaglia ◽  
Chiara Pasotti ◽  
Raffaele Manni ◽  
...  

2011 ◽  
Vol 122 ◽  
pp. S48-S49
Author(s):  
R. Di Giacopo ◽  
P. Mariotti ◽  
G. Della Marca ◽  
D. Quaranta ◽  
A. Bentivoglio

PLoS ONE ◽  
2016 ◽  
Vol 11 (8) ◽  
pp. e0160199 ◽  
Author(s):  
Si-Fei Huang ◽  
Kui Chen ◽  
Jian-Jun Wu ◽  
Feng-Tao Liu ◽  
Jue Zhao ◽  
...  

SLEEP ◽  
2019 ◽  
Vol 42 (Supplement_1) ◽  
pp. A124-A124
Author(s):  
Jonathan Trout ◽  
Taylor Christiansen ◽  
Ariel Escobar ◽  
M Brooks Bulkley ◽  
Jared J Tanner ◽  
...  

2016 ◽  
Vol 26 ◽  
pp. 62-66 ◽  
Author(s):  
Maria Salsone ◽  
Basilio Vescio ◽  
Alessandra Fratto ◽  
Miriam Sturniolo ◽  
Gennarina Arabia ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Patama Gomutbutra ◽  
Kittika Kanjanaratanakorn ◽  
Nantaporn Tiyapun

Background. Previous studies have shown that Parkinson’s disease (PD) patients who have REM behavior disorder (PD with RBD) might be a PD subtype since they have different symptom clusters and disease trajectories from PD without RBD. Objective. To study the prevalence of PD with pRBD and to compare the clinical characteristics with PD without pRBD. The feasibility of clinical interview of items adopted from the Mayo Sleep Questionnaire was also to be determined. Methods. A total of 140 Parkinson's patients visiting neurological clinics during January to December 2016 were enrolled in this study. “Probable RBD (pRBD)” was defined as present when the patient answered “yes” to a question adapted from the first Mayo Sleep Questionnaire (MSQ). The demographic data, motor symptoms, and nonmotor symptoms were obtained. Results. The prevalence of pRBD among this study’s PD patients was 48.5% (68 out of the total of 140). The median onset of RBD before PD diagnosis was 5 years (range: 0–11 years). By comparison of PD with pRBD and PD without pRBD, this study showed significant difference in the levodopa equivalent dose (742 mg/day versus 566 mg/day; p<0.01), prevalence of symptomatic orthostatic hypotension (35.3% versus 8.3%; p<0.01). The multivariable analysis found that pRBD is independently associated with orthostatic hypotension (OR = 5.02, p<0.01). Conclusion. The findings regarding prevalence and main clinical features of PD with pRBD in this study were similar to those of a previous study of PD with polysomnogram- (PSG-) proven RBD. This study hypothesized that interviewing by adopted MSQ may be a cost-effective tool for screening RBD. Further studies with direct comparison are needed.


SLEEP ◽  
2019 ◽  
Vol 42 (Supplement_1) ◽  
pp. A32-A33
Author(s):  
Jonathan Trout ◽  
Taylor Christiansen ◽  
M Brooks Bulkley ◽  
Ariel Escobar ◽  
Jared J Tanner ◽  
...  

2021 ◽  
Author(s):  
Milan Nigam ◽  
Ines Ayadi ◽  
Camille Noiray ◽  
Ana Catarina Branquino‐Bras ◽  
Erika Herraez Sanchez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document